Dr. Reddy’s Laboratories submits press release

28 Nov 2024 Evaluate

Dr. Reddy’s Laboratories has submitted a Press Release on “Dr. Reddy's launches Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma.”

The above information is a part of company’s filings submitted to BSE.


Dr. Reddys Lab Share Price

1275.05 27.05 (2.17%)
18-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.30
Dr. Reddys Lab 1275.05
Cipla 1472.05
Lupin 2098.70
Zydus Lifesciences 979.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.